Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Amgen reported strong Q1 results with a 9% YoY revenue increase and a 24% rise in operating EPS, but shares dipped due to risk-on market sentiment. Despite competitive pressures and softer EPS trends, ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13 ...

Today, Benzinga's options scanner spotted 9 options trades for Amgen. This is not a typical pattern. The sentiment among ...

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more ...

What Happened: Khosla's recent move involves selling 890 shares of Amgen. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total value ...

Amgen (AMGN) has caught some attention as its shares continued their upward trend in June, with the stock delivering a 13% ...